Mitochondrial Endonuclease Activities Specific for Apurinic/apyrimidinic Sites in DNA from Mouse Cells
Overview
Authors
Affiliations
Endonuclease activity which specifically cleaves baseless (apurinic/apyrimidinic (AP] sites in supercoiled DNA has been purified from mitochondria of the mouse plasmacytoma cell line, MPC-11. Two variant forms separate upon purification; these have small but reproducible differences in catalytic and chromatographic properties, but similar physical properties. Both have a sedimentation coefficient of 4.0, corresponding to a molecular weight of 61,000 (assuming a globular configuration) and a peptide molecular weight of about 65,000 as determined by immunoblot analysis with antiserum raised against the major AP endonuclease from HeLa cells. Thus mitochondrial AP endonuclease appears to be a monomer of about 65 kDa, making it distinguishable from the major AP endonuclease of MPC-11 cells which, like those of other mammalian cells, appears to be a monomer of about 41 kDa. A possible 82-kDa precursor form was also detected by immunoblot analysis of a crude mitochondrial fraction. Mitochondrial AP endonuclease activity is greatly stimulated by divalent cations, has a pH optimum between 6.5 and 8.5, and cleaves the AP site by a class II mechanism to generate a 3'-OH nucleotide residue. These properties resemble those of the major mammalian AP endonucleases but, unlike those enzymes, mitochondrial AP endonuclease activity is neither inhibited by adenine or NAD+ nor stimulated by Triton X-100. Since the mitochondrial activity generates active primer termini for DNA synthesis, it could function in base excision DNA repair; alternatively, it might have a role in eliminating damaged mitochondrial genomes from the gene pool.
Xue Z, Demple B Antioxidants (Basel). 2022; 11(9).
PMID: 36139891 PMC: 9495735. DOI: 10.3390/antiox11091817.
Bazzani V, Barchiesi A, Radecka D, Pravisani R, Guadagno A, Di Loreto C BMC Cancer. 2020; 20(1):969.
PMID: 33028238 PMC: 7542375. DOI: 10.1186/s12885-020-07258-6.
Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma.
Liu Y, Zhang Z, Li Q, Zhang L, Cheng Y, Zhong Z Oncol Rep. 2020; 44(2):499-508.
PMID: 32627008 PMC: 7336412. DOI: 10.3892/or.2020.7633.
Hao J, Du H, Liu F, Lu J, Yang X, Cui W Exp Ther Med. 2019; 17(3):2143-2151.
PMID: 30867702 PMC: 6395998. DOI: 10.3892/etm.2019.7212.
The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease.
Desler C, Lillenes M, Tonjum T, Rasmussen L Curr Med Chem. 2017; 25(40):5578-5587.
PMID: 28618998 PMC: 6446443. DOI: 10.2174/0929867324666170616110111.